Clinical Trial Update: Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether N-acetylcysteine can prevent contrast-induced nephropathy after catheterization in diabetic patients with chronic ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Contrast-induced Nephropathy
• Diabetes Mellitus

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Radiocontrast-Induced Nephropathy, Chronic Kidney Disease | Phase 3 | Status: COMPLETED